The bill amends Chapter 5-37.8 of the General Laws, known as the "Protections for Healthcare Providers Act," by adding a new section, 5-37.8-4, which establishes prescriptive protections for providers engaged in legally protected healthcare activities. Specifically, it mandates that the prescription label for medication abortion prescription drugs must display the name of the healthcare practice that dispenses the medication rather than the name of the individual dispenser. This change aims to enhance the confidentiality and protection of healthcare providers involved in providing medication abortions.

Additionally, the bill defines "medication abortion prescription drugs" as substances used to induce the termination of a pregnancy, including but not limited to mifepristone and misoprostol. The act is set to take effect immediately upon passage, reinforcing the legislative intent to safeguard healthcare providers in the context of abortion-related services.